- Report
- August 2025
- 198 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
- Report
- August 2025
- 194 Pages
Global
From €3161EUR$3,545USD£2,754GBP
€3512EUR$3,939USD£3,060GBP
Probenecid is a drug used in animal pharmaceuticals to treat gout and other conditions. It is a uricosuric agent, meaning it helps the body to excrete uric acid, which is a byproduct of purine metabolism. Probenecid is also used to increase the effectiveness of certain antibiotics, such as penicillin, by preventing their excretion from the body. It is available in both injectable and oral forms.
Probenecid is used in veterinary medicine to treat gout, arthritis, and other conditions. It is also used to increase the effectiveness of certain antibiotics, such as penicillin, by preventing their excretion from the body. It is available in both injectable and oral forms.
The Probenecid market is highly competitive, with a number of companies offering products for animal pharmaceuticals. Some of the major players in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Bayer Animal Health. Show Less Read more